OPTICAL RESOLUTION IN THE INOSITOLPHOSPHATE SERIES

Information

  • Research Project
  • 3498423
  • ApplicationId
    3498423
  • Core Project Number
    R43GM043654
  • Full Project Number
    1R43GM043654-01
  • Serial Number
    43654
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/1/1990 - 35 years ago
  • Project End Date
    8/14/1990 - 34 years ago
  • Program Officer Name
  • Budget Start Date
    2/1/1990 - 35 years ago
  • Budget End Date
    8/14/1990 - 34 years ago
  • Fiscal Year
    1990
  • Support Year
    1
  • Suffix
  • Award Notice Date
    12/28/1989 - 35 years ago
Organizations

OPTICAL RESOLUTION IN THE INOSITOLPHOSPHATE SERIES

The overall objective of this study is to develop a simple, general, and practical method for resolving derivatives of DL-myo-inositol into D- and L- enantiomers. A novel approach based on putative enantioselective hydrolysis catalyzed by hydrolase enzymes is suggested. The pure enantiomers are required as key synthons for the preparation of D- myo inositol-1,4,5-trisphosphate, the myo-inositol-1-phosphono-6-glycans, and , other compounds related to these intracellular second messenger molecules, and for the synthesis of analogues as potential therapeutic agents. The Phase I program is designed to establish the feasibility of the general approach. For this, the hydrolysis of selected DL-myo-inositol esters as model substrates, catalyzed by a number of hydrolase enzymes will be studied to determine relationships between structural features and esterase activity, with emphasis on synthons for the preparation of D-myo-inositol- 1-phosphate, D-myo-inositol-1,4,5-trisphosphate, and their L-enantiomers. During Phase II, the general approach will be extended and applied for the preparation of other members of the phosphoinositol series derived from the phosphatidylinositol metabolic cycle, and to the design, synthesis and evaluation of their structural and biochemical analogues.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    NUTRIMED BIOTECH
  • Organization Department
  • Organization DUNS
  • Organization City
    ITHACA
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    14850
  • Organization District
    UNITED STATES